Latest Breaking News On - Holm keller - Page 4 : vimarsana.com

AchilleS Vaccines Completes Industrial Development of Promising Treatment Against SARS-CoV-2

Press release content from Business Wire. The AP news staff was not involved in its creation. AchilleS Vaccines Completes Industrial Development of Promising Treatment Against SARS-CoV-2 January 25, 2021 GMT AchilleS Vaccines Completes Industrial Development of Promising Treatment Against SARS-CoV-2 (Photo: AchilleS Vaccines) KALKARA, Malta & SIENA, Italy--(BUSINESS WIRE)--Jan 25, 2021-- Today, AchilleS Vaccines, a biotech company based in Siena (Italy), announced the successful industrial development of a novel monoclonal antibody (mAb) to treat COVID-19. The treatment, patented by Prof Rino Rappuoli’s MAD Lab and developed by AchilleS, could greatly improve access to COVID-19 treatment and has several advantages compared to conventional mAbs: it can be administered intramuscularly, avoiding the risks of hospitalization. Additionally, this mAb is highly potent and the low dosage treatment offers significant health and cost benefits.

Governments Spent at Least 93bn on COVID-19 Vaccines and Therapeutics During the Last 11 Months